WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018

Jun 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-06-11

Reporting Person: Malone Daniel (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-11	Common Stock	M	5000.00	$16.045	Acquired	34020.3934	Direct
2018-06-11	Common Stock	S	5000.00	$97.24	Disposed	29020.3934	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-11	Stock Options (Right to Buy)	$16.045	M	5000.00	Disposed	2019-02-24	Common Stock (5000.00)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $97.11 USD to $97.28 USD; the price reported above reflects the weighted average sale price.

F2: This award vests in 4 equal annual installments beginning on February 24, 2010.